You can tell from action of the stock. It was very close miss in one aspect but quite good on others. According to conference call, even the very close miss on breast cancer, is much better than any drug out there. I think they can get approval and will sell well until something better comes along.
warning label in this case is actually good thing, really, go study this thing a little bit. This increases iron, which paitience need, but warning says be careful adding another Iron medication that you would normally do, you may not need it.
what in the world are you talking about? they are not even same drug. Auryxia is phosphate binders with iron replacement benefit. Auryxia sales in Japan are doing very well and growing fast, I don't see why it would be different here. I think once it gets going, sales will accelerate.
This is a trust that has no expenses, it receives royalty on revenues. So even if operators lose money, we receive net dollars based on revenue. having no expense, and no debt, there is no chance of demise. we can only make money, we can't lose, a sweet deal.
There are 2 positives happening right now, first the Ultradeep's first well at 75 million cubic feet / day is a very nice well, and there is a lot more on the way. Second, the water oil separation processing bottleneck which has held back production should be resolved by now. So, baby load up on this going back to 20s soon.
Wow, this is going to run to $30, to $40 range soon. Huge short, and news getting better and better and very few float. This will start moving in Dollars instead of cents soon
They don't have a new drug, they have a portable pump for administering the existing drug. I will see if I could short it. The word Parkingson has got people excited.